INNOVATIVE MEDTECH, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Innovative Medtech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q1 2024.
  • Innovative Medtech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$910K, a 13.8% decline year-over-year.
  • Innovative Medtech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$2.13M, a 89.6% increase year-over-year.
  • Innovative Medtech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.65M, a 79.8% increase from 2022.
  • Innovative Medtech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.1M, a 453% decline from 2021.
  • Innovative Medtech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.26M, a 567% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$2.13M -$910K -$110K -13.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$2.02M -$188K +$789K +80.7% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-20
Q3 2023 -$2.81M -$165K +$835K +83.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-05-20
Q2 2023 -$3.65M -$871K +$16.8M +95.1% Apr 1, 2023 Jun 30, 2023 10-K 2023-10-13
Q1 2023 -$20.5M -$800K -$878K -1119% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$19.6M -$977K -$778K -391% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-20
Q3 2022 -$18.8M -$1M -$741K -286% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-20
Q2 2022 -$18.1M -$17.7M -$17M -2400% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 -$1.09M $78.5K +$2.25M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$3.33M -$199K -$38.9K -24.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-15
Q3 2021 -$3.29M -$259K -$28.9K -12.5% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-15
Q2 2021 -$3.26M -$707K Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 -$2.17M Jan 1, 2021 Mar 31, 2021 10-K 2022-10-13
Q4 2020 -$160K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-22
Q3 2020 -$230K Jul 1, 2020 Sep 30, 2020 10-Q 2022-02-22
Q1 2014 -$258K $286K +$302K Feb 1, 2014 Apr 30, 2014 10-Q 2021-02-01
Q4 2013 -$560K -$190K +$7.11K +3.6% Nov 1, 2013 Jan 31, 2014 10-Q 2021-02-01
Q3 2013 -$567K -$337K +$596K +63.9% Aug 1, 2013 Oct 31, 2013 10-K 2021-02-01
Q2 2013 -$1.16M -$16.2K +$8.25K +33.8% May 1, 2013 Jul 31, 2013 10-Q 2021-02-01
Q1 2013 -$1.17M -$16.2K +$123K +88.4% Feb 1, 2013 Apr 30, 2013 10-Q 2021-02-01
Q4 2012 -$1.29M -$197K +$194K +49.6% Nov 1, 2012 Jan 31, 2013 10-Q 2021-02-01
Q3 2012 -$1.49M -$934K Aug 1, 2012 Oct 31, 2012 10-K 2021-02-01
Q2 2012 -$24.4K May 1, 2012 Jul 31, 2012 10-Q 2021-02-01
Q1 2012 -$139K +$264K +65.5% Feb 1, 2012 Apr 30, 2012 10-Q 2021-02-01
Q4 2011 -$392K -$104K -36.1% Nov 1, 2011 Jan 31, 2012 10-Q 2021-02-01
Q1 2011 -$403K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-19
Q4 2010 -$288K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.